|
|
| | HC≡C-CH2-PEG3-SH Basic information |
| Product Name: | HC≡C-CH2-PEG3-SH | | Synonyms: | HC≡C-CH2-PEG3-SH;Propargyl-PEG3-SH;Ethanethiol, 2-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]-;2-{2-[2-(prop-2-yn-1-yloxy)ethoxy]ethoxy}ethane-1-thiol | | CAS: | 1412905-18-0 | | MF: | C9H16O3S | | MW: | 204.29 | | EINECS: | | | Product Categories: | | | Mol File: | 1412905-18-0.mol |  |
| | HC≡C-CH2-PEG3-SH Chemical Properties |
| Boiling point | 286.2±30.0 °C(Predicted) | | density | 1.053±0.06 g/cm3(Predicted) | | pka | 9+-.0.10(Predicted) |
| | HC≡C-CH2-PEG3-SH Usage And Synthesis |
| Uses | Propargyl-PEG3-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Propargyl-PEG3-SH is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | Biological Activity | Propargyl-PEG3-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | IC 50 | PEGs | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | HC≡C-CH2-PEG3-SH Preparation Products And Raw materials |
|
|
Tag:HC≡C-CH2-PEG3-SH(1412905-18-0)
Related Product Information
|
|
2-[2-(Prop-2-ynyloxy)ethoxy]ethan-1-ol
propargyl-PEG3-Acid
3,6,9,12,15-Pentaoxahexadecane-1-thiol
Propargyl-PEG6-CH2COOH
Propargyl-PEG4-thiol
2,5,8,11,14,17,20,23,26-Nonaoxaoctacosane-28-thiol
Propargyl-PEG2-Thiol
HC≡C-CH2-PEG8-SH
2,5,8,11,14,17,20-Heptaoxadocosane-22-thiol
HC≡C-CH2-PEG6-SH
|